Harvard Bioscience EBITDA 2010-2023 | HBIO

Harvard Bioscience ebitda from 2010 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Harvard Bioscience Annual EBITDA
(Millions of US $)
2023 $9
2022 $1
2021 $10
2020 $9
2019 $8
2018 $9
2017 $3
2016 $1
2015 $3
2014 $11
2013 $6
2012 $12
2011 $13
2010 $14
2009 $12
Harvard Bioscience Quarterly EBITDA
(Millions of US $)
2023-12-31 $2
2023-09-30 $1
2023-06-30 $3
2023-03-31 $4
2022-12-31 $2
2022-09-30 $-2
2022-06-30 $6
2022-03-31 $-5
2021-12-31 $4
2021-09-30 $2
2021-06-30 $2
2021-03-31 $2
2020-12-31 $6
2020-09-30 $2
2020-06-30 $3
2020-03-31 $-1
2019-12-31 $4
2019-09-30 $1
2019-06-30 $2
2019-03-31 $2
2018-12-31 $4
2018-09-30 $3
2018-06-30 $2
2018-03-31 $1
2017-12-31 $1
2017-09-30 $1
2017-06-30 $1
2017-03-31 $1
2016-12-31 $-0
2016-09-30 $0
2016-06-30 $0
2016-03-31 $1
2015-12-31 $1
2015-09-30 $0
2015-06-30 $1
2015-03-31 $0
2014-12-31 $3
2014-09-30 $2
2014-06-30 $3
2014-03-31 $2
2013-12-31 $0
2013-09-30 $1
2013-06-30 $2
2013-03-31 $2
2012-12-31 $6
2012-09-30 $1
2012-06-30 $2
2012-03-31 $2
2011-12-31 $5
2011-09-30 $1
2011-06-30 $4
2011-03-31 $3
2010-12-31 $4
2010-09-30 $3
2010-06-30 $3
2010-03-31 $4
2009-12-31 $4
2009-09-30 $3
2009-06-30 $2
2009-03-31 $3
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.166B $0.112B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Mettler-Toledo (MTD) United States $26.730B 32.82
Bruker (BRKR) United States $11.486B 30.63
Kewaunee Scientific (KEQU) United States $0.103B 12.11